Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(3.19)
# 2,496
Out of 4,520 analysts
176
Total ratings
48.8%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintained: Hold | $1,275 | $1,310.02 | -2.67% | 4 | Jul 10, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $620 | $532.48 | +16.44% | 4 | Jul 10, 2026 | |
| IQV IQVIA Holdings | Maintained: Hold | $225 → $200 | $206.26 | -3.04% | 5 | Jul 10, 2026 | |
| TEM Tempus AI | Maintained: Buy | $70 | $52.47 | +33.41% | 5 | Jul 10, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $185 → $260 | $224.35 | +15.89% | 6 | Jul 9, 2026 | |
| WAT Waters | Rated: Hold | $350 → $390 | $368.98 | +5.70% | 4 | Jul 9, 2026 | |
| WST West Pharmaceutical Services | Rated: Hold | $325 → $365 | $358.24 | +1.89% | 9 | Jul 9, 2026 | |
| VCYT Veracyte | Rated: Sell | $37 → $47 | $59.13 | -20.51% | 5 | Jul 9, 2026 | |
| NTRA Natera | Rated: Buy | $250 → $310 | $271.39 | +14.23% | 5 | Jul 9, 2026 | |
| GH Guardant Health | Rated: Buy | $130 → $175 | $155.87 | +12.27% | 6 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9 → $13 | $15.39 | -15.53% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $20 | $22.92 | -12.74% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $37 | $43.74 | -15.41% | 5 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $19.17 | -0.89% | 9 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $16.93 | +12.23% | 2 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $131.46 | +21.71% | 5 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $24.88 | +40.68% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $5.5 | $4.62 | +19.05% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 | $72.62 | -17.38% | 5 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $184 | $203.83 | -9.71% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $11.07 | -9.67% | 1 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $68 | $77.00 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $182 | $50.60 | n/a | 12 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $110.88 | n/a | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $3.25 | n/a | 11 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $4.30 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $17.38 | n/a | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $260 | $318.32 | n/a | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $11 | $8.54 | n/a | 4 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $5.03 | n/a | 14 | Dec 3, 2024 |
Mettler-Toledo International
Jul 10, 2026
Maintained: Hold
Price Target: $1,275
Current: $1,310.02
Upside: -2.67%
Thermo Fisher Scientific
Jul 10, 2026
Maintained: Buy
Price Target: $620
Current: $532.48
Upside: +16.44%
IQVIA Holdings
Jul 10, 2026
Maintained: Hold
Price Target: $225 → $200
Current: $206.26
Upside: -3.04%
Tempus AI
Jul 10, 2026
Maintained: Buy
Price Target: $70
Current: $52.47
Upside: +33.41%
Charles River Laboratories International
Jul 9, 2026
Rated: Buy
Price Target: $185 → $260
Current: $224.35
Upside: +15.89%
Waters
Jul 9, 2026
Rated: Hold
Price Target: $350 → $390
Current: $368.98
Upside: +5.70%
West Pharmaceutical Services
Jul 9, 2026
Rated: Hold
Price Target: $325 → $365
Current: $358.24
Upside: +1.89%
Veracyte
Jul 9, 2026
Rated: Sell
Price Target: $37 → $47
Current: $59.13
Upside: -20.51%
Natera
Jul 9, 2026
Rated: Buy
Price Target: $250 → $310
Current: $271.39
Upside: +14.23%
Guardant Health
Jul 9, 2026
Rated: Buy
Price Target: $130 → $175
Current: $155.87
Upside: +12.27%
Jul 9, 2026
Rated: Hold
Price Target: $9 → $13
Current: $15.39
Upside: -15.53%
Jul 9, 2026
Maintained: Hold
Price Target: $18 → $20
Current: $22.92
Upside: -12.74%
Jul 9, 2026
Maintained: Hold
Price Target: $22 → $37
Current: $43.74
Upside: -15.41%
Jun 10, 2026
Maintained: Hold
Price Target: $19
Current: $19.17
Upside: -0.89%
Jun 5, 2026
Maintained: Buy
Price Target: $19
Current: $16.93
Upside: +12.23%
May 28, 2026
Reiterated: Buy
Price Target: $160
Current: $131.46
Upside: +21.71%
May 15, 2026
Maintained: Hold
Price Target: $35
Current: $24.88
Upside: +40.68%
May 12, 2026
Rated: Hold
Price Target: $6 → $5.5
Current: $4.62
Upside: +19.05%
May 12, 2026
Maintained: Hold
Price Target: $60
Current: $72.62
Upside: -17.38%
Apr 23, 2026
Rated: Buy
Price Target: $270 → $184
Current: $203.83
Upside: -9.71%
Feb 13, 2026
Maintained: Hold
Price Target: $10
Current: $11.07
Upside: -9.67%
Jul 15, 2025
Maintained: Buy
Price Target: $100 → $68
Current: $77.00
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: $200 → $182
Current: $50.60
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $130 → $160
Current: $110.88
Upside: n/a
May 20, 2025
Maintained: Hold
Price Target: $20 → $15
Current: $3.25
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $10
Current: $4.30
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $19
Current: $17.38
Upside: n/a
Apr 24, 2025
Maintained: Hold
Price Target: $260
Current: $318.32
Upside: n/a
Feb 27, 2025
Maintained: Hold
Price Target: $10 → $11
Current: $8.54
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $5.03
Upside: n/a